WRBY vs. PEN, STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, and INSP
Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.
Warby Parker vs. Its Competitors
Penumbra (NYSE:PEN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.
Penumbra currently has a consensus price target of $302.93, suggesting a potential upside of 18.98%. Warby Parker has a consensus price target of $24.06, suggesting a potential downside of 11.20%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Warby Parker.
88.9% of Penumbra shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 5.0% of Penumbra shares are owned by insiders. Comparatively, 18.2% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Warby Parker had 1 more articles in the media than Penumbra. MarketBeat recorded 11 mentions for Warby Parker and 10 mentions for Penumbra. Penumbra's average media sentiment score of 1.35 beat Warby Parker's score of 0.87 indicating that Penumbra is being referred to more favorably in the media.
Penumbra has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500.
Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.12%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.
Summary
Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.
Get Warby Parker News Delivered to You Automatically
Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Warby Parker Competitors List
Related Companies and Tools
This page (NYSE:WRBY) was last updated on 9/17/2025 by MarketBeat.com Staff